Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
68.53 BRL | -5.23% | -5.23% | -0.91% |
11:02am | Hutchmed China notes Takeda obtains EU approval for Fruzaqla | AN |
10:45am | Takeda's Organ Transplant Infection Treatment Approved by Japan Regulators | MT |
Chart: Technical Analysis
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- 4502 Stock
- TAKP34 Stock
- Charts Takeda Pharmaceutical Company Limited